Abstract:Objective To evaluate peripheral blood circulating CD34+ cell count in patients with myelodysplastic syndrome(MDS)-refractory anemia(RA)/refractory anemia with ring siderblasts(RARS)/refractory cytopenia with multilineage dysplasia(RCMD).Methods A total of 52 MDS-RA/RARS/RCMD patients and 19 hematopoietic stem cell donors(healthy controls) were enrolled,and their peripheral blood circulating CD34+ cell percentages and counts were determined byflow cytometry. They were classified into low risk, intermediate-Ⅰ risk,intermediate-Ⅱ risk,high risk subgroups and very low risk,low risk, intermediate risk,high risk, very high risk subgroups according to the International Prognostic Scoring System(IPSS) and World Health Organization (WHO)-Based Prognostic Scoring System(WPSS),respectively. The correlation of peripheral blood circulating CD34+ cell count with the clinical characteristics of MDS-RA/RARS/RCMD patients was analyzed.Results MDS-RA/RARS/RCMD patients had higher percentage and count of peripheral blood circulating CD34+ cells compared with healthy controls(P<0.01). There was no correlation between peripheral blood circulating CD34+ cell count inMDS-RA/RARS/RCMD patients and patients' sex,age,cytopenia degree,white blood cell count decreasing and abnormal localization of immature precursor(ALIP)(r<0.625,P>0.05),and there was correlation between peripheral blood circulating CD34+ cell count and abnormal karyotype,IPSS score, WPSS score and myelofibrosis (r>0.995,P<0.01). There were 16 MDS-RA/RARS/RCMD patients with peripheral blood circulating CD34+ cell count >10.00×106/L. Among them, there were 12 patients with complex karyotype abnormalities(10 patients with chromosome 7 abnormalities). A total of 12 and 13 patients belonged to IPSS intermediate-Ⅱ risk and WPSS high risk subgroups,respectively. There were 9 patients with myelofibrosis. Among 36 MDS-RA/RARS/RCMD patients with peripheral blood circulating CD34+ cell count <10.00×106/L,no patient had complex karyotype abnormalities or chromosome 7 abnormalities. Except for 1 patient in WPSS high risk subgroup,other patients were in IPSS low,intermediate-Ⅰ risk subgroups and WPSS very low,low and intermediate risk subgroups. Only 1 patient had myelofibrosis.Conclusions The count of peripheral blood circulating CD34+ cells increases in MDS-RA/RARS/RCMD patients,which can be further used for the classification of MDS risk.

[Analysis of Lymphocyte Subsets in Peripheral Blood of Patients with Aplastic Anemia or Hypoplastic Myelodysplastic Syndrome]

Comparison of T lymphocyte subsets in aplastic anemia and hypoplastic myelodysplastic syndromes

The ratio of bone marrow myeloid progenitor cell proportion to mature lymphocytes proportion can effectively differentiate aplastic anemia and hypoplastic myelodysplastic syndrome and evaluate the quality of bone marrow aspirates

Laboratory Study and Clinical Features of Hypoplastic Myelodysplastic Syndrome

Clinical and Biological Characteristics of Acute Myeloid Leukemia with 20-29% Blasts: a Retrospective Single-Center Study

Cytogenetic Abnormalities Predict Disease Progression in Primary Myelodysplastic Syndrome: A Multicentric Study in 508 Chinese Patients.

[Karyotype Analysis of 283 Cases of Myelodysplastic Syndrome].

Analysis of the Karyotype Abnormalities and Its Prognostic in 298 Patients with Myelodysplastic Syndrome

A study on T - cell subgroup in peripheral blood of children with aplastic anemia

Performance of Automatic Blood Cell Analysis Parameters for Differential Diagnosis of Myelodysplastic Syndromes and Aplastic Anemia

A flow cytometric approach to compare stem cell apoptosis in aplastic anemia and hypoplastic myelodysplastic syndrome

[Quantitative Analysis of Dendritic Cell Subsets in Bone Marrow of Patients with Acute Myeloid Leukemia].

[Expressions of CD117 and CD11b in Patients with APL at Diagnosis and Post-Treatment].

Analysis of Mean Corpuscular Volume and Red Cell Distribution Width in Patients with Aplastic Anemia

Clinical study of the number of circulating CD34~+ cells in the peripheral blood from patients with myelodysplastic syndromes

Reduced Regulatory Effects of Bone Marrow-Derived Mesenchymal Stem Cells on Activated T Lymphocytes and Th1/Th2 Cytokine Secretion in Children with Aplastic Anemia.

[The Value of Flow Cytometry for the Differential Diagnosis Between Refractory Cytopenia with Multiple Dysplasia and Aplastic Anemia].

The Ratio of Absolute Lymphocyte Count at Interim of Therapy to Absolute Lymphocyte Count at Diagnosis Predicts Survival in Childhood B-lineage Acute Lymphoblastic Leukemia.

Clinical analysis for thirty patients with myelodysplastic syndromes

Dysplasia features of myelodysplastic syndrome in ethnically Chinese people

Peripheral blood circulating CD34+ cell count in patients with MDS-RA/RARS/RCMD